Neural Circuit Mechanisms of Disorders of Consciousness and Potential Therapeutic Targets of Brain Stimulation
CNS Neuroscience & Therapeutics · 2026-09 · 32 (9)
DOI: 10.1002/cns.71037 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 06.09.2026. Verfasst von Yichen Zhou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Deep Brain Stimulation, Consciousness Disorders, Brain, Nerve Net. Die Arbeit nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: International (Hong Kong, Macao, and Taiwan) Science and Technology Cooperation Project, Science and Technology Innovation 2030, Chinese Institute for Brain Research Youth Scholar Program.
Abstract (Originalsprache)
Background
Disorders of consciousness (DoC) lack an integrated framework to guide neuromodulation. This review updates three hierarchical frameworks—ARAS, mesocircuit, and ICNs—and maps therapeutic targets within each.
Methods
We synthesized recent neuroanatomical, optogenetic, neuroimaging, and clinical trial evidence, reevaluating classic frameworks and proposing a hierarchical integration to inform multi‐target strategies.
Results
Three major updates are identified. In ARAS, glutamatergic neurons in PPN/LDT and parabrachial nucleus, rather than cholinergic neurons, are the primary arousal drivers; clinical translation relies on peripheral nerve stimulations with variable efficacy. The mesocircuit is expanded from a unidirectional GPi‐mediated pathway to a bidirectional GPi–GPe balance modulated by dopamine and adenosine; DBS targeting CM‐Pf/CL shows ~44.7% response rate (38/85) but lacks RCTs, whereas amantadine remains the sole Level 1 evidence. Within ICNs, the executive control network has the strongest RCT support, though efficacy depends on etiology and consciousness level; salience network stimulation is untested. These frameworks are hierarchically integrated: ARAS sustains wakefulness, mesocircuit enables cortical activation, and ICNs support conscious content.
Conclusion
Future strategies should adopt multi‐target, multi‐level approaches grounded in individualized network profiling. Priorities include large‐scale RCTs for DBS and stratified protocols based on etiology and consciousness level.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
- Department of Neurosurgery, Aviation General Hospital, Beijing, China.
- China National Clinical Research Center for Neurological Diseases, Beijing, China.
- Innovative Center, Beijing Institute of Brain Disorders, Beijing, China.
- Department of Neurosurgery, Chinese Institute for Brain Research, Beijing, China.
ORCID-Profile: Yichen Zhou, Sipeng Zhu, Qiheng He, Yitong Jia, Xiaoke Chai, Nan Wang, Yi Yang
Förderung
- International (Hong Kong, Macao, and Taiwan) Science and Technology Cooperation Project
- Science and Technology Innovation 2030
- Chinese Institute for Brain Research Youth Scholar Program
- National Natural Science Foundation of China
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Zhou, Y., Cao, T., Zhu, S., He, Q., Jia, Y., Chai, X., Wang, N., & Yang, Y. (2026). Neural Circuit Mechanisms of Disorders of Consciousness and Potential Therapeutic Targets of Brain Stimulation. CNS Neuroscience & Therapeutics, 32(9). https://doi.org/10.1002/cns.71037
Vancouver
Zhou Y, Cao T, Zhu S, He Q, Jia Y, Chai X, et al. Neural Circuit Mechanisms of Disorders of Consciousness and Potential Therapeutic Targets of Brain Stimulation. CNS Neuroscience & Therapeutics. 2026;32(9). doi:10.1002/cns.71037
BibTeX
@article{Zhou2026,
author = {Zhou, Yichen and Cao, Tianqing and Zhu, Sipeng and He, Qiheng and Jia, Yitong and Chai, Xiaoke and Wang, Nan and Yang, Yi},
title = {Neural Circuit Mechanisms of Disorders of Consciousness and Potential Therapeutic Targets of Brain Stimulation},
journal = {CNS Neuroscience & Therapeutics},
year = {2026},
volume = {32},
number = {9},
doi = {10.1002/cns.71037}
}
EUVIMED